Phoenix Biotech Acquisition Corp. (PBAXU) es una empresa que cotiza en bolsa en el Servicios Financieros sector, operando dentro de la Shell Companies industria. La empresa tiene su sede en Oakland, CA, United States. El CEO actual es Christopher B. Ehrlich.
PBAXU tiene fecha de IPO 2021-10-06, cotiza en el NASDAQ Global Market, una capitalización de mercado de $36.54M.
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, California.
